Perrigo Company PLC (NYSE:PRGO)
| 41.41 BATS BZX Real-Time Price As of 9:51am ET |  +0.24 / +0.58%Today’s Change | 38.20 Today|||52-Week Range 58.83 | -7.40% Year-to-Date |
Latest PRGO News | Press Releases
No recent news for Perrigo Company PLC.
Today’s Trading
| Previous close | 41.17 |
| Today’s open | 41.20 |
| Day’s range | 41.20 - 41.54 |
| Volume | 67,305 |
| Average volume (3 months) | 1,264,182 |
| Market cap | $5.4B |
Data as of 9:51am ET, 04/16/2021
Growth & Valuation
| Earnings growth (last year) | -211.21% |
| Earnings growth (this year) | -34.79% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +4.67% |
| P/E ratio | NM |
| Price/Sales | 1.20 |
| Price/Book | 0.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRPTSarepta Therapeutics... | -0.31 | -0.43% |
| IONSIonis Pharmaceutical... | -0.43 | -1.05% |
| ALLKAllakos Inc | +0.96 | +0.89% |
| GLPGGalapagos NV | +0.07 | +0.09% |
Data as of 9:54am ET, 04/16/2021
Financials
| Next reporting date | May 12, 2021 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $5.1B |
| Annual profit (last year) | -$162.6M |
| Net profit margin | -3.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
